Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.
Mulder K, Lim H, Ravi D, Ahmed S, Brunet B, Davies J, Doll C, Dueck DA, Gordon V, Hebbard P, Kim CA, Le D, Lee-Ying R, McGhie JP, Park J, Renouf DJ, Schellenberg D, Wong RPW, Zaidi A, Ahmed S. Mulder K, et al. Curr Oncol. 2022 Apr 29;29(5):3160-3170. doi: 10.3390/curroncol29050257. Curr Oncol. 2022. PMID: 35621647 Free PMC article.
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.
Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R. Ahmed S, et al. Among authors: mulder k. Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362. Curr Oncol. 2015. PMID: 25908916 Free PMC article.
Effects of gender on capecitabine toxicity in colorectal cancer.
Ilich AI, Danilak M, Kim CA, Mulder KE, Spratlin JL, Ghosh S, Chambers CR, Sawyer MB. Ilich AI, et al. J Oncol Pharm Pract. 2016 Jun;22(3):454-60. doi: 10.1177/1078155215587345. Epub 2015 May 22. J Oncol Pharm Pract. 2016. PMID: 26002954
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
Lui A, Mulder K, Brezden-Masley C, Vickers M, Monzon J, Kennecke H, Goel R, Vos L, Ghosh S, Marginean H, Fields A, Maroun J, Spratlin J. Lui A, et al. Among authors: mulder k. Invest New Drugs. 2018 Aug;36(4):674-682. doi: 10.1007/s10637-018-0599-4. Epub 2018 May 4. Invest New Drugs. 2018. PMID: 29725881 Clinical Trial.
306 results